Lifetime Exposure to Lower LDL-C and Lower Systolic Blood Pressure and Cardiovascular Disease ja.ma/2MGtQIq

So, to recap: first I ask him about symptoms. If he is asymptomatic, I leave him alone. If he has symptoms, I ask a CCTA. If he has CAD on CCTA but not of the left main, then I explain the pros and cons of the invasive strategy. Finally I give him some colchicine. #AHA19

ISCHEMIA Trial by VisualMed Henry Han SABOURETCardiologist Mamas A. Mamas Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Yury Mareev Nikolay Novitskiy SCAI #cardiotwitter

DIURESIS-CHF: In this small trial acetazolamide + low-dose bumetanide VS high-dose bumetanide increased natriuresis & 'efficacy of loop-diuretic' in #AHF + high-risk for diuretic resistance. Will ADVOR RCT confirm this data? bit.ly/2qRN4nn #cardiotwitter #EJHF

#Coronahero oil on 4 x 5 foot canvas by C. Michael Gibson. Inspired by a photograph by Alberto Giuliani. #cmgsees

Our heroes. #NationalSuperHeroDay (🖊️: Mike Hawthorne, 🎨: @delgaduck)

Why do we use the meds we use in HFrEF? The critical studies that shape the modern approach to HF mgmt. Anything I missed that you would add? #cardiotwitter #medtwitter #ACCFIT #EBM #TipsForNewDocs HFSA

Quando eu acho que já vi quase tudo... Vem alguém sexista e misógino fazer um "estudo" desse tipo. Absurdo. Pior é que foi revisado pela revista e publicado. #MedBikini #WomenInMedicine

Excellent presentation by the incomparable #bonnieky at the SBC/ACC #cardioonc meeting today discussing priorities and future directions submit your science to advance the field to #JACCCardioOnc

Happy for this viewpoint!!

On demand Cardio-Onc education, and available FREE of charge for 2021! #cardioonc Eric H Yang, MD International Cardio-Oncology Society The James

** NOTA URGENTE** Vamos arrumar o que a brilhante comunicação do governo de SP esta estragando. OS RESULTADOS DA CORONAVAC SÃO MUITO BONS! Eles tem impactos na estratégia de uso, eles tem limitações, mas eles são bons mesmo. Muito melhores que a pataquada da comunicação oficial

Resumo, você tem 50% menos chance de pegar COVID19 e uma redução de quase 80% em casos que precisam de médico, talvez mais que isso nos mais graves. Dos vacinados, ai sim, a maioria so teve uma gripinha que não precisa de médico. "COVID19 vira gripinha" na maior parte dos casos

.European Society of Cardiology welcomes the #EUCancerPlan proposal to strengthen the multidisciplinary #cancer workforce. With growing numbers of patients presenting more than one condition #integratedcare is vital. Cancer should not be treated in isolation.

Diagnosis, risk stratification and management of myocarditis bit.ly/3JeIQca

⚠️2022 European Society of Cardiology Guidelines on #cardiooncology #CardioTwitter #ESC22 #ESCRME Radcliffe Cardiology

ICOS proudly announces the European Society of Cardiology guidelines in #CardioOncology . Summary of many years of work. Over 200 new recommendations ESTRO ESH (Haematology) Teresa Lopez Fernandez @sdent_duke Dinesh Thavendiranat Javid Moslehi

COURGAE: we don’t treat these patients ORBITA: we don’t treat these patients ISCHEMIA: we don’t treat these patients REVIVED: we don’t treat these patients. Seriously? Time to accept PCI has limited roles outside of ACS. 🤷🏽 #Cardiotwitter

Champions of the first ICOS Champions League! It's not about the competition, but to try to demonstrate how much I care and take cardio-oncology seriously and how worthwhile it is to study! Thank you so much for this opportunity International Cardio-Oncology Society

Now starts the Advancing Cardiovascular Care of the Oncology Patient. Get ready. Team Brazil is on ☺️ #BrazilCardioOncConnect American College of Cardiology Ariane V. Scarlatelli Macedo Ana Barac, MD, PhD, FACC, FAHA